Changes in preoperative characteristics in patients undergoing radical prostatectomy – a 16-year nationwide analysis

References

• Outzen M, Brasso K, Martinussen N, Christensen J, Tjonneland A, Friis S, et al. Prostate cancer in Denmark 1978-2. Acta Oncol 2013;52:831–6.
   PubMed Web of Science ®Google Scholar
• Mukai TO, Bro F, Pedersen KV, Vedsted P. [Use of prostate-specific antigen testing]. Ugeskr Laeger 2010;172:696–700.
   PubMedGoogle Scholar
• Roder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, et al. Survival after radical prostatectomy for clinically localised prostate cancer: A population-based study. Br J Urol Int Epub 2013 Mar 15.
   Google Scholar
• Walter S, Colstrup H. [Transrectal ultrasonography of the prostate]. Ugeskr Laeger 2001;163:891.
   PubMedGoogle Scholar
• Iversen P, Brasso K. [Diagnosis of prostatic cancer – transrectal biopsy]. Ugeskr Laeger 2011;173:1783.
   PubMedGoogle Scholar
• Sobin LH. TNM, 6th ed.: New developments in general concepts and rules. Semin Surg Oncol 2003;21:19–22.
   Google Scholar
• Epstein JI, Allsbrook WC, Jr., Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228–42.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969–74.
   PubMed Web of Science ®Google Scholar
• Rietbergen JB, Hoedemaeker RF, Kruger AE, Kirkels WJ, Schroder FH. The changing pattern of prostate cancer at the time of diagnosis: Characteristics of screen detected prostate cancer in a population based screening study. J Urol 1999;161:1192–8.
   PubMed Web of Science ®Google Scholar
• Budaus L, Spethmann J, Isbarn H, Schmitges J, Beesch L, Haese A, et al. Inverse stage migration in patients undergoing radical prostatectomy: Results of 8916 European patients treated within the last decade. Br J Urol Int 2011;108: 1256–61.
   Google Scholar
• Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M, et al. Comparison of stage migration patterns between Europe and the USA: An analysis of 11 350 men treated with radical prostatectomy for prostate cancer. Br J Urol Int 2008;101:1513–8.
   Google Scholar
• Silberstein JL, Vickers AJ, Power NE, Fine SW, Scardino PT, Eastham JA, et al. Reverse stage shift at a tertiary care center: Escalating risk in men undergoing radical prostatectomy. Cancer 2011;117:4855–60.
   PubMed Web of Science ®Google Scholar
• Finne P, Fallah M, Hakama M, Ciatto S, Hugosson J, de KH, et al. Lead-time in the European randomised study of screening for prostate cancer. Eur J Cancer 2010;46: 3102–8.
   PubMed Web of Science ®Google Scholar
• Etzioni R, Mucci L, Chen S, Johansson JE, Fall K, Adami HO. Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Clin Cancer Res 2012; 18:6742–7.
   PubMed Web of Science ®Google Scholar
• Dall’Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, et al. Active surveillance for prostate cancer: A systematic review of the literature. Eur Urol 2012;62:976–83.
   PubMed Web of Science ®Google Scholar
• Thomsen FB, Roder MA, Hvarness H, Iversen P, Brasso K. Active surveillance can reduce overtreatment in patients with low-risk prostate cancer. Dan Med J 2013;60:A4574.
   Google Scholar
• Statistics Denmark. Life expectancy tables. Available from: www.statistikbanken.dk/HISB8. [cited 2013 Feb 1]
   Google Scholar
• Helpap B, Egevad L. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch 2006;449:622–7.
   PubMed Web of Science ®Google Scholar
• Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, et al. Contemporary grading for prostate cancer: Implications for patient care. Eur Urol 2013;63:892–901.
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011;364: 1708–17.
   PubMed Web of Science ®Google Scholar
• Vickers A, Bennette C, Steineck G, Adami HO, Johansson JE, Bill-Axelson A, et al. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian prostate cancer group randomized trial. Eur Urol 2012; 62:204–9.
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203–13.
   PubMed Web of Science ®Google Scholar